# Correction: Omole et al. Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. Vaccines 2025, 13, 192

**Authors:** Tosin Omole, Enrique Pelayo, Aaron S. Weinberg, Spyros Chalkias, Zelalem Endale, Gretchen Tamms, Tina M. Sterling, Lori Good, Tulin Shekar, Morgan Johnson, Natalie Banniettis, Ulrike K. Buchwald, Alejandra Esteves-Jaramillo

PMC · DOI: 10.3390/vaccines13101056 · Vaccines · 2025-10-16

## Full-text entities

- **Chemicals:** PCV15 (-)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12568176/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12568176/full.md

---
Source: https://tomesphere.com/paper/PMC12568176